Zobrazeno 1 - 10 of 533 pro vyhledávání: '"Michael C, Perry"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
ASCO Remembers Michael C. Perry, MD.
Publikováno v: Journal of Clinical Oncology; Jan2012 Supplement, p36-36, 1p
Zobrazit plný text záznamu
9
Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trial
Autor: Zhongwu Lai, Darren Hodgson, Brian Dougherty, J. Carl Barrett, Tsveta Milenkova, Elizabeth A. Harrington, Jessica S Brown, Eric Pujade-Lauraine, Simon Dearden, Alexandra Leary, Jerry S. Lanchbury, Michael C. Perry, Cathy E. Elks, Kirsten Timms
Publikováno v: Gynecologic oncology. 163(3)
Objective Maintenance olaparib provided a progression-free survival benefit in the phase III SOLO2 trial (NCT01874353) in patients with platinum-sensitive relapsed ovarian cancer and a BRCA mutation (BRCAm). However, questions remain regarding tumor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f015e6502a0b6bdc67dd4e5e6c4f5aa9
https://pubmed.ncbi.nlm.nih.gov/34742578
Zobrazit plný text záznamu
10
Akademický článek
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy( The following institutions participated in this study: Cancer and Leukemia Group B Statistical Office, Durham, NC (Stephen George, Ph.D., supported by CA33601); Dartmouth Medical School–Norris Cotton Cancer Center, Lebanon, NH (Marc Ernstoff, MD, supported by CA04326); Georgetown University Medical Center, Washington, DC (Edward P. Gelmann, M.D., supported by CA77597); Massachussetts General Hospital, Boston, MA (Michael L. Grossbard, M.D., supported by CA12449); Mount Sinai School of Medicine, New York, NY (Lewis Silverman, M.D., supported by CA04457); North Shore–Long Island Jewish Medical Center, Manhasset, NY (Daniel R. Budman, M.D., supported by CA35279); Rhode Island Hospital, Providence, RI (William Sikov, M.D., supported by CA08025); Roswell Park Cancer Institute, Buffalo, NY (Ellis Levine, M.D., supported by CA02599); SUNY Upstate Medical University, Syracuse, NY (Stephen L. Graziano, M.D., supported by CA21060); University of California at San Diego, San Diego, CA (Stephen Seagren, M.D., supported by CA11789); University of Maryland Cancer Center, Baltimore, MD (David Van Echo, M.D., supported by CA31983); University of Pretoria, Pretoria, South Africa; University of Missouri-Ellis Fischel Cancer Center, Columbia, MO (Michael C. Perry, M.D., supported by CA12046); Wake Forest University School of Medicine, Winston-Salem, NC (David D. Hurd, M.D., supported by CA03927); Walter Reed Army Medical Center, Washington, DC (Joseph J. Drabeck, M.D., supported by CA26806); Weill Medical College of Cornell University, New York, NY (Michael Schuster, M.D., supported by CA07968); Western Pennsylvania Cancer Institute, Pittsburgh, PA (Richard K. Shadduck, M.D.).The current study was performed for the Cancer and Leukemia Group B (CALGB), Chicago, IL.)
Autor: Alice B. Kornblith, James E. Herndon, Raymond B. Weiss, Chunfeng Zhang, Enid L. Zuckerman, Sylvia Rosenberg, Magriet Mertz, David Payne, Mary Jane Massie, James F. Holland, Patti Wingate, Larry Norton, Jimmie C. Holland
Publikováno v: Cancer (0008543X); 8/15/2003, Vol. 98 Issue 4, p679, 11p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje